Microbot Medical MBOT Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's cash provided by (used in) operating activity, including discontinued operation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Microbot Medical's cash provided by (used in) operating activity, including discontinued operation?
- Microbot Medical (MBOT) reported cash provided by (used in) operating activity, including discontinued operation of -$5.05M in Q1 2026.
- How has Microbot Medical's cash provided by (used in) operating activity, including discontinued operation changed year-over-year?
- Microbot Medical's cash provided by (used in) operating activity, including discontinued operation decreased by 75.8% year-over-year, from -$2.87M to -$5.05M.
- What is the long-term trend for Microbot Medical's cash provided by (used in) operating activity, including discontinued operation?
- Over 4 years (2021 to 2025), Microbot Medical's cash provided by (used in) operating activity, including discontinued operation has grown at a 8.7% compound annual growth rate (CAGR), from -$9.35M to -$13.05M.
- What does cash provided by (used in) operating activity, including discontinued operation mean?
- Measures the cash generated from the company's core business operations, excluding financing and investing activities. It reflects the ability of the company to convert revenue into actual cash flow after accounting for changes in working capital.